ESR1 and breast cancer: In order to fully address the impact of reduced PTEN levels on PI3K activation and endocrine response, we created models of ER+/human epidermal growth factor receptor 2 (HER2)-negative (−) breast cancer with reduced PTEN by inducible knockdown (KD).